Essling Capital
Essling Capital is a Paris-based independent private equity manager spun out of Massena Partners in 2017 (AMF GP-17000016, SIREN 827573783), specialised in PE co-investment, GP-led secondaries and lead-investment vehicles for European mid- and large-cap buyout deals. The firm manages and advises around EUR 650 million across a co-investment vehicle family (Essling Co-Invest 1 through 4, vintages 2017 to 2025) plus a healthcare thematic co-invest, lead-investment vehicles and a GP-led secondaries strategy launched 2025. Tickets typically range from EUR 5 to 30 million per deal, sector-agnostic, alongside leading European GPs. Realised exits include Evolucare (sold to GPI Group 2023), Crouzet (sold to Tikehau Ace Capital and Bpifrance 2022) and MMV (sold to La Compagnie des Alpes 2022).
Essling Capital is a Paris buyout firm with €650M AUM, 15 active companies and 4 exits.
- ·3 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 4 realized deals: 4 years.
- ·Fund cadence: ~1Y between vintages · last raise 2024.
Sector breakdown
19 companiesGeography breakdown
5 geographiesKey facts
Recent exits
Essling Capital sold Caillau to Montyon Capital in 2025 after 7 years.
Essling Capital sold Evolucare to GPI Group in 2023 after 4 years.
Essling Capital sold Crouzet to Tikehau Ace Capital and Bpifrance in 2022 after 4 years.
Essling Capital sold Duff & Phelps to Permira in 2018 after 2 years.
Coverage notes
6 funds tracked, 19 portfolio companies (15 active · 4 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Essling Capital has raised, with its portfolio companies. Hand-checked from public filings.
Essling Co-Invest 4Buyout2024€120M0 assetsBuyout2024 · 2yr€120M0–
No portfolio companies tracked yet.
Essling Co-Invest HealthcareActiveGrowth2022€100M0 assetsGrowth2022 · 4yr€100M0–
No portfolio companies tracked yet.
Essling Co-Invest 3RealizedBuyout2019€120M4 assetsBuyout2019 · 7yr€120M4–
Essling ExpansionGrowth2019€200M4 assets1 exitsGrowth2019 · 7yr€200M41
Unrealized
4 held| Company | Entry |
|---|---|
| SPVIE Assurances InsurTech · France | 2020 |
| Teknimed MedTech · France | 2021 |
| TrustBuilder Cybersecurity · France | 2021 |
| X-Ray Phocea Healthcare · France | 2023 |
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Evolucare HealthTech · France | 2019 | 2023 | Trade Sale | GPI Group | – |
Essling Co-Invest 2RealizedBuyout2018€100M3 assets2 exitsBuyout2018 · 8yr€100M32
Unrealized
3 held| Company | Entry |
|---|---|
| Hamburg Commercial Bank Financials · Germany | 2018 |
| Kiloutou Construction · France | 2018 |
| Minimax Viking Group Construction · Germany | 2018 |
Essling Co-Invest 1RealizedBuyout2017€100M4 assets1 exitsBuyout2017 · 9yr€100M41
Unrealized
4 held| Company | Entry |
|---|---|
| Brunel Group Consumer · France | 2016 |
| GetBack Financials · Poland | 2017 |
| Staples Consumer · US | 2017 |
| The Reefer Group Logistics · France | 2016 |
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Duff & Phelps Financials · US | 2016 | 2018 | Secondary | Permira | – |
About Essling Capital
Essling Capital is a French private equity and investment platform with capital deployed across 1 active fund vehicles, headquartered in Paris. The firm operates across multiple alternative strategies, with capital deployed into European businesses across industrials, TMT, financials and healthcare.
Investment thesis
Essling Capital operates across complementary alternative investment strategies, deploying capital into European businesses across industrials, TMT, financials and healthcare. The multi-strategy platform enables diversified capital deployment across the business lifecycle from venture and growth equity to mid-cap buyouts, with capital sourced from institutional limited partners and selective family-office capital across France and selectively across Europe.
Recent activity
Recent realised exits include Participation Wb Crouzet (industrials, 2022). The platform tracks 1 dedicated investment vehicle, 16 active portfolio companies and 3 realised exits across the strategy's history.
Frequently asked questions
- What investment strategy does Essling Capital focus on?
- Essling Capital focuses on Buyout, Growth strategies in the private equity space.
- How many portfolio companies does Essling Capital have?
- Essling Capital has 15 active portfolio companies and 4 completed exits and 6 funds tracked on GP Intel.
- Where is Essling Capital headquartered?
- Essling Capital is headquartered in Paris, France.
- What is Essling Capital's assets under management?
- Essling Capital manages approximately €650M in assets under management.
- When was Essling Capital founded?
- Essling Capital was founded in 2017.
- What sectors does Essling Capital invest in?
- Essling Capital invests across Industrials, TMT, Financials, Healthcare, Consumer.
- What are Essling Capital's recent exits?
- Recent realized exits by Essling Capital include: Caillau (2025) to Montyon Capital; Evolucare (2023) to GPI Group; Crouzet (2022) to Tikehau Ace Capital and Bpifrance; Duff & Phelps (2018) to Permira.
Similar firms
Other private equity firms tracked on GP Intel.